Bb Biotech Ag Raised Holding in Incyte Corp. (INCY) by $3.13 Million; Manning & Napier Advisors Increased Its Automatic Data Processing In (ADP) Position by $1.59 Million

December 7, 2017 - By Adrian Mccoy

Manning & Napier Advisors Llc increased its stake in Automatic Data Processing In (ADP) by 21.03% based on its latest 2017Q2 regulatory filing with the SEC. Manning & Napier Advisors Llc bought 15,580 shares as the company’s stock declined 1.06% while stock markets rallied. The institutional investor held 89,678 shares of the technology company at the end of 2017Q2, valued at $9.19M, up from 74,098 at the end of the previous reported quarter. Manning & Napier Advisors Llc who had been investing in Automatic Data Processing In for a number of months, seems to be bullish on the $51.41 billion market cap company. The stock increased 0.21% or $0.24 during the last trading session, reaching $115.92. About 2.09 million shares traded. Automatic Data Processing, Inc. (NASDAQ:ADP) has risen 15.83% since December 7, 2016 and is uptrending. It has underperformed by 0.87% the S&P500.

Bb Biotech Ag increased its stake in Incyte Corp. (INCY) by 0.72% based on its latest 2017Q2 regulatory filing with the SEC. Bb Biotech Ag bought 25,000 shares as the company’s stock rose 9.08% with the market. The institutional investor held 3.51M shares of the commercial physical & biological resarch company at the end of 2017Q2, valued at $442.55M, up from 3.49M at the end of the previous reported quarter. Bb Biotech Ag who had been investing in Incyte Corp. for a number of months, seems to be bullish on the $19.79 billion market cap company. The stock increased 0.09% or $0.08 during the last trading session, reaching $93.79. About 1.27M shares traded. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since December 7, 2016 and is uptrending. It has outperformed by 56.14% the S&P500.




Among 19 analysts covering Automatic Data (NASDAQ:ADP), 4 have Buy rating, 2 Sell and 13 Hold. Therefore 21% are positive. Automatic Data had 47 analyst reports since August 3, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Equal-Weight” rating and $114 target in Tuesday, November 14 report. On Tuesday, July 18 the stock rating was downgraded by Barclays Capital to “Equal-Weight”. The firm has “Outperform” rating given on Monday, August 31 by William Blair. The rating was maintained by Citigroup with “Neutral” on Friday, July 29. As per Friday, December 16, the company rating was upgraded by Goldman Sachs. The stock of Automatic Data Processing, Inc. (NASDAQ:ADP) has “Hold” rating given on Wednesday, August 30 by Robert W. Baird. As per Tuesday, July 11, the company rating was maintained by BMO Capital Markets. The stock has “Outperform” rating by Bernstein on Monday, July 11. The firm earned “Sell” rating on Thursday, October 29 by Topeka Capital Markets. Wedbush initiated the stock with “Neutral” rating in Friday, September 9 report.

More notable recent Automatic Data Processing, Inc. (NASDAQ:ADP) news were published by: Nasdaq.com which released: “Automatic Data Processing a Top Ranked SAFE Dividend Stock With 2.3% Yield (ADP)” on November 21, 2017, also Nasdaq.com with their article: “See Which Of The Latest 13F Filers Holds Automatic Data Processing” published on November 16, 2017, Seekingalpha.com published: “ADP: I Misjudged The Valuation” on December 05, 2017. More interesting news about Automatic Data Processing, Inc. (NASDAQ:ADP) were released by: Nasdaq.com and their article: “CME Group Takes Over #114 Spot From Automatic Data Processing” published on November 28, 2017 as well as Fortune.com‘s news article titled: “Billionaire Activist Investor Bill Ackman Just Lost a Big Board Seat Battle” with publication date: November 07, 2017.

Manning & Napier Advisors Llc, which manages about $52.21B and $11.63 billion US Long portfolio, decreased its stake in China Biologic Prods Inc (NASDAQ:CBPO) by 10,570 shares to 71,755 shares, valued at $8.11M in 2017Q2, according to the filing. It also reduced its holding in Thermo Fisher Scientific Inc (NYSE:TMO) by 55,793 shares in the quarter, leaving it with 271,710 shares, and cut its stake in Dollar Gen Corp New (NYSE:DG).

Investors sentiment decreased to 0.77 in Q2 2017. Its down 0.06, from 0.83 in 2017Q1. It is negative, as 62 investors sold ADP shares while 426 reduced holdings. 74 funds opened positions while 304 raised stakes. 355.68 million shares or 2.28% more from 347.76 million shares in 2017Q1 were reported. Stephens Ar holds 0.24% or 67,788 shares. Aspen Invest Mngmt reported 6,638 shares. Jane Street Gru Ltd Company has invested 0.01% in Automatic Data Processing, Inc. (NASDAQ:ADP). Chevy Chase reported 0.22% stake. Illinois-based Whitnell has invested 1.05% in Automatic Data Processing, Inc. (NASDAQ:ADP). Mutual Of America Mngmt Lc has 54,549 shares. Davenport Ltd Liability Co holds 17,588 shares or 0% of its portfolio. Fukoku Mutual Life Insur holds 0.05% or 3,000 shares in its portfolio. 285,924 are held by Donaldson Capital Llc. Employees Retirement Of Ohio holds 0.17% or 308,594 shares. Lourd Cap Ltd Liability has invested 0.05% in Automatic Data Processing, Inc. (NASDAQ:ADP). Beach Investment Management Limited Company stated it has 22,160 shares. 40,788 were reported by Novare Capital Mgmt Limited Liability. Ronna Sue Cohen has invested 1.87% of its portfolio in Automatic Data Processing, Inc. (NASDAQ:ADP). Bridges Invest owns 2,647 shares or 0.04% of their US portfolio.

More notable recent Incyte Corporation (NASDAQ:INCY) news were published by: Livetradingnews.com which released: “Incyte Corporation (NASDAQ:INCY) Bullish Divergence” on November 27, 2017, also Globenewswire.com with their article: “MacroGenics Announces Closing of MGA012 Global Collaboration and License …” published on December 05, 2017, Nasdaq.com published: “Incyte is Now Oversold (INCY)” on December 04, 2017. More interesting news about Incyte Corporation (NASDAQ:INCY) were released by: Businesswire.com and their article: “Incyte Announces Initiation of Pivotal Clinical Trial of Ruxolitinib (Jakafi” published on November 15, 2017 as well as Seekingalpha.com‘s news article titled: “Incyte: Depressed Valuation With Catalysts Coming” with publication date: December 02, 2017.

Since June 12, 2017, it had 0 buys, and 1 sale for $1.95 million activity.

Investors sentiment decreased to 1.02 in 2017 Q2. Its down 0.39, from 1.41 in 2017Q1. It worsened, as 57 investors sold INCY shares while 158 reduced holdings. 67 funds opened positions while 153 raised stakes. 184.77 million shares or 0.98% less from 186.59 million shares in 2017Q1 were reported. Huntington Bancorp holds 0% in Incyte Corporation (NASDAQ:INCY) or 300 shares. 11,167 were reported by Advsr Asset Mgmt Incorporated. 180 were accumulated by Whittier Trust Co Of Nevada. Group Inc One Trading Ltd Partnership holds 0.04% or 29,787 shares in its portfolio. Mirae Asset Invs Communications Limited, Korea-based fund reported 16,903 shares. Eagle Asset Incorporated holds 0.16% in Incyte Corporation (NASDAQ:INCY) or 209,861 shares. Addison invested in 0.69% or 6,822 shares. Bancorporation Of Montreal Can accumulated 89,931 shares. Fjarde Ap reported 39,604 shares or 0.1% of all its holdings. Moreover, Rock Springs Lp has 1.1% invested in Incyte Corporation (NASDAQ:INCY). Jane Street Grp Inc Lc holds 3,002 shares or 0% of its portfolio. Northern Trust reported 0.06% stake. Metropolitan Life Insurance Company Ny invested 0.08% of its portfolio in Incyte Corporation (NASDAQ:INCY). Platinum Management Ltd owns 13,464 shares or 0.05% of their US portfolio. Great Lakes Advsr Ltd invested in 0.02% or 7,254 shares.

Among 23 analysts covering Incyte (NASDAQ:INCY), 19 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 72 analyst reports since August 6, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Tuesday, June 20 report. On Wednesday, October 5 the stock rating was maintained by Jefferies with “Hold”. The rating was maintained by JMP Securities with “Market Outperform” on Monday, October 10. The firm has “Buy” rating by BMO Capital Markets given on Sunday, August 27. Oppenheimer maintained it with “Hold” rating and $13500 target in Wednesday, July 5 report. The firm has “Buy” rating by Brean Capital given on Wednesday, September 2. Suntrust Robinson initiated the stock with “Buy” rating in Friday, August 5 report. The stock of Incyte Corporation (NASDAQ:INCY) earned “Buy” rating by Cowen & Co on Sunday, June 4. RBC Capital Markets maintained the shares of INCY in report on Wednesday, February 15 with “Outperform” rating. The rating was maintained by Nomura with “Buy” on Tuesday, October 6.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: